Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.
about
Mannose 6-phosphate/insulin-like growth factor-II receptor targets the urokinase receptor to lysosomes via a novel binding interactionGenetic control of the innate immune responseUveal Melanoma Metastasis ModelsDual role for plasminogen activator inhibitor type 1 as soluble and as matricellular regulator of epithelial alveolar cell wound healingPlasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth.Directional migration and transcriptional analysis of oligodendrocyte precursors subjected to stimulation of electrical signal.Non-muscle alpha-actinin-4 interacts with plasminogen activator inhibitor type-1 (PAI-1).Epitope mapping for four monoclonal antibodies against human plasminogen activator inhibitor type-1: implications for antibody-mediated PAI-1-neutralization and vitronectin-binding.The plasmin cascade and matrix metalloproteinases in non-small cell lung cancerBreast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cyclePhosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.Polymorphisms in genes controlling inflammation and tissue repair in rheumatoid arthritis: a case control study.Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy.Antimetastatic potential of PAI-1-specific RNA aptamers.The molecular basis for anti-proteolytic and non-proteolytic functions of plasminogen activator inhibitor type-1: roles of the reactive centre loop, the shutter region, the flexible joint region and the small serpin fragment.Old dogs and new tricks: proteases, inhibitors, and cell migration.Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins.Plasminogen activator inhibitor-1 in the pathogenesis of asthma.Effects of plasminogen activator inhibitor-1-specific RNA aptamers on cell adhesion, motility, and tube formation.Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations.Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity.Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo.PAI-1 and functional blockade of SNAI1 in breast cancer cell migration.Mechanisms underlying the antifibrotic properties of noninhibitory PAI-1 (PAI-1R) in experimental nephritis.Plasminogen Activator Inhibitor-1 and Diagnosis of the Metabolic Syndrome in a West African Population.Plasminogen activator inhibitor-1 inhibitors: a patent review (2006-present).Involvement of urokinase-type plasminogen activator system in cancer: an overview.Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosisAntisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.Plasminogen activator inhibitor-1 (PAI-1) modifies the formation of aggressive fibromatosis (desmoid tumor).Role of mesenchymal stem cell-derived fibrinolytic factor in tissue regeneration and cancer progression.Elevated Tumor Expression of PAI-1 and SNAI2 in Obese Esophageal Adenocarcinoma Patients and Impact on Prognosis.Plasminogen activator inhibitors regulate cell adhesion through a uPAR-dependent mechanism.The shed ectodomain of type XIII collagen affects cell behaviour in a matrix-dependent manner.The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1.Tumor necrosis factor alpha up-regulates in an autocrine manner the synthesis of plasminogen activator inhibitor type-1 during induction of monocytic differentiation of human HL-60 leukemia cells.PAI-1 gene expression is regionally induced in wounded epithelial cell monolayers and required for injury repair.Developmental differences in the expression and modulation of extracellular matrix proteases and inhibitors in mouse skin fibroblasts.Plasminogen activator inhibitor 1 protects fibrosarcoma cells from etoposide-induced apoptosis through activation of the PI3K/Akt cell survival pathway.A regulatory hydrophobic area in the flexible joint region of plasminogen activator inhibitor-1, defined with fluorescent activity-neutralizing ligands. Ligand-induced serpin polymerization.
P2860
Q24683196-3FAD1CCC-51FA-4C48-A1ED-AB3C7B6842E6Q24800607-3E3664AF-F753-4518-9C82-D9B099731303Q26750387-57DD6DFA-C1B6-4741-9014-57578228A882Q28580473-EAA2AB36-311B-46F1-AAFB-8CE27DDE6B24Q30307084-9193F9EA-0B97-46A6-82D4-C2A9946AE9F2Q30668977-87697245-BAB4-4FF4-80B4-3948F96E1E8EQ31121826-545BEAFA-3B34-41DD-912D-EAFD508E2DA3Q31944726-60286E77-6DED-4B06-8B97-E6994F18C24BQ33634208-5B2BFD5A-D424-4A1A-B4A6-1AE8259AF697Q33715393-CE8DEC92-7DD8-4B27-BEB9-7C5CA45462E6Q33725701-D6C7C88D-3A27-4834-8640-37AB8660B1EBQ33840136-6F0EEC42-7936-4D07-80B5-F1BD4D3641A3Q33894600-C1863ECA-46FC-4BE5-B389-F86167F6338FQ34167905-CF542F56-7BFD-4FEB-BDFF-3567F84FAFF4Q34584787-AA80F73A-47E5-4A1A-B81C-2E50E48E4636Q35167706-0C03EA47-797E-4AFF-AE57-03BE737EED99Q35219000-739909FF-72E7-40EE-922E-C6EFA1442333Q35634264-60CEEE0F-CC4D-4A39-8584-A8B3CFB41ED9Q35757741-000D2B9D-6F1C-4F26-ADD3-66DE193B362BQ35788649-475A016F-0C55-470F-8A6B-F1B404EC9C80Q36162638-71D14AD5-B954-463C-B793-EDFF0A6627C2Q36401755-CF858634-7084-473A-AB0A-48A16FFC4B7FQ37131335-3C4BBD54-C942-4152-8FB1-EB3B57E33CDAQ37417240-3AE9789C-31FE-4A5B-82A1-95483E8EDA80Q37434624-5AC1C21B-A851-4769-8DD8-C4B966AAEE35Q38092174-F779EEAC-81B3-44C2-8145-355BF0370C72Q38189275-0CE8E834-9D61-495D-8E7D-ED5143B45D4BQ38274802-D73C77FD-5368-4518-AA9A-AB270C89356EQ38303693-301BAC1F-EAC4-4FA9-8F79-45A7DA0A3358Q38331352-B81E8655-C967-43CB-BDBF-105FAF3FFB9FQ38583085-0B421462-5624-42CD-9A22-207E14CD76CCQ39226627-795212F3-E652-41A6-85A9-E2C411FCF5EAQ39846676-085D5958-0D5A-4279-A7D9-B4A7FB8EFD3BQ40581317-F87037B0-AB7F-4E5D-9924-2B42B83E86BCQ40582221-DB024EBE-A45E-4E7A-8F1E-E6393DF3B0CCQ40903271-BA24A1BC-F5A4-49EA-A4FE-2631FAE2AF89Q40907981-A1A56B23-146E-40C5-827C-57EC5511CE8FQ41713863-E018CEDE-B517-4721-A15C-DCC4B9F6FE43Q42136467-43A1E0BC-6033-43E7-A929-0EFF8E086E7BQ43559468-878D0D74-9E70-4968-A26A-F238C258CCAF
P2860
Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Plasminogen activator inhibito ...... tor of plasminogen activation.
@en
type
label
Plasminogen activator inhibito ...... tor of plasminogen activation.
@en
prefLabel
Plasminogen activator inhibito ...... tor of plasminogen activation.
@en
P2093
P356
P1476
Plasminogen activator inhibito ...... tor of plasminogen activation.
@en
P2093
Andreasen PA
Goodman SL
Kirkegaard T
Ossowski L
Preissner KT
Rodenburg KW
P304
P356
10.1006/EXCR.1997.3540
P407
P577
1997-05-01T00:00:00Z